SCHEMBL2569501

SCHEMBL2569501

CCN(CC)C(=O)c1ccccc1-c1cn(CC2CCCCC2)c(C(C)(C)C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
HIF1A Q16665 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CNR2 P34972 3/20 0.38
OPRD1 P41143 3/20 0.38
OPRM1 P35372 2/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
HCRTR1 O43613 6/20 0.36
HCRTR2 O43614 6/20 0.36
KEAP1 Q14145 1/20 0.36
CNR1 P21554 3/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KCNH2 Q12809 1/20 0.35
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2571039 0.87 CNR2 (0.42) CNR2PDE4APDE4BPDE4CPDE4D
SCHEMBL2572113 0.87 CNR2 (0.40) CNR2PDE4APDE4BPDE4CPDE4D
SCHEMBL2574009 0.83 ALDH1A1 (0.41) ALDH1A1LMNACNR2OPRD1PDE4A
SCHEMBL2572403 0.82 CNR2 (0.38) CNR2CNR1KCNH2
SCHEMBL2570252 0.82 OPRD1 (0.43) ALDH1A1CNR2OPRD1OPRM1CNR1
SCHEMBL2570136 0.82 BRD4 (0.45) LMNACNR2OPRD1OPRM1CNR1
SCHEMBL2569347 0.79 CNR1 (0.37) CNR2PDE4APDE4BPDE4CPDE4D
SCHEMBL2572002 0.79 CNR2 (0.41) NPSR1CNR2PDE4APDE4BPDE4C
SCHEMBL2569171 0.78 TLR8 (0.42) CNR2PDE4APDE4BPDE4CPDE4D
SCHEMBL2571623 0.78 CNR2 (0.41) NPSR1CNR2PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120289502-A1 IMIDAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-11-15 US disclosed
US-8273738-B2 Imidazole derivatives KYOWA HAKKO KIRIN CO., LTD. (JP) 2012-09-25 US disclosed
EP-2090570-B1 IMIDAZOLE DERIVATIVE KYOWA HAKKO KIRIN CO LTD (JP) 2011-11-09 EP disclosed
US-20100152178-A1 IMIDAZOLE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-17 US disclosed
EP-2090570-A1 IMIDAZOLE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2009-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289502-A1 IMIDAZOLE DERIVATIVES CNR1, CNR2, ARRB1 ALDH1A1 2997/4885LMNA 4117/4885HTT 4268/4885
US-20100152178-A1 IMIDAZOLE DERIVATIVES CNR1, CNR2, ARRB1 ALDH1A1 2997/4885LMNA 4117/4885HTT 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.